Skip to main content
AAN.com

Abstract

Objective: To describe a sporadic motor neuron disorder that remains largely restricted to the upper limbs over time.
Background: Progressive amyotrophy that is isolated to the upper limbs in an adult often suggests ALS. The fact that weakness can remain largely confined to the arms for long periods of time in individuals presenting with this phenotype has not been emphasized.
Methods: We reviewed the records of patients who had a neurogenic “man-in-the-barrel” phenotype documented by examination at least 18 months after onset. These patients had severe bilateral upper-extremity neurogenic atrophy that spared lower-extremity, respiratory, and bulbar musculature.
Results: Nine of 10 patients meeting these criteria had a purely lower motor neuron disorder. During follow-up periods ranging from 3 to 11 years from onset, only three patients developed lower-extremity weakness, and none developed respiratory or bulbar dysfunction or lost the ability to ambulate.
Conclusion: Patients presenting with severe weakness that is fully isolated to the upper limbs, without pyramidal signs, may have a relatively stable variant of motor neuron disease.

Get full access to this article

View all available purchase options and get full access to this article.

References

1.
Sage JI, Van Uitert RL. Man-in-the-barrel syndrome. Neurology 1986;36:1102–1103.
2.
Crisostomo EA, Suslavich FJ. Man-in-the-barrel syndrome associated with closed head injury. J Neuroimaging 1994;4:116–117.
3.
Wilck EJ, Gerard PS, Keilson M, Bashevkin M, Lieberman J. Symmetrical cerebral metastasis presenting with bilateral upper extremity weakness. J Neuroimaging 1996;6:254–256.
4.
Moore AP, Humphrey PR. Man-in-the-barrel syndrome caused by cerebral metastases. Neurology 1989;39:1134–1135.
5.
Alberca R, Iriarte LM, Rasero P, Villalobos F. Brachial diplegia in central pontine myelinolysis. J Neurol 1985;231:345–346.
6.
Adams RD, Victor M, Ropper AH. Principals of neurology. 6th ed. New York:MacGraw-Hill, 1985:1089–1094.
7.
Brooks BR, Sufit RL, DePaul R, DeTan Y, Sanjak M, Robbins JA. Design of clinical therapeutic trials in amyotrophic lateral sclerosis. Adv Neurol 1991;56:521–546.
8.
Caroscio JT, Mulvihill MN, Sterling R, Abrams B. Amyotrophic lateral sclerosis: its natural history. Neurol Clin 1987;5:1–8.
9.
Gubbay SS, Kahana E, Zilber N, Cooper G, Pintov S, Leibowitz Y. Amyotrophic lateral sclerosis: a study of its presentation and prognosis. J Neurol 1985;232:295–300.
10.
Mulder DW. The clinical syndrome of amyotrophic lateral sclerosis. Mayo Clin Proc 1957;32:427–436.
11.
Berg D, Müllges W, Koltzenburg M, Bendszus M, Reiners K. Man-in-the-barrel syndrome caused by cervical spinal cord infarction. Acta Neurol Scand 1998;97:417–419.
12.
Pullicino P. Bilateral distal upper limb amyotrophy and watershed infarcts from vertebral dissection. Stroke 1994;25:1870–1872.
13.
Kameyama T, Ando T, Yanagi T, Yasui K, Sobue G. Cervical spondylotic amyotrophy. Spine 1998;23:448–452.
14.
Dorsen M, Ehni G. Cervical spondylotic radiculopathy producing motor manifestations mimicking primary muscular atrophy. Neurosurgery 1979;5:427–431.
15.
Lalu T, Mercier B, Birouk N, et al. Pure motor neuropathy after radiation therapy: 6 cases. Rev Neurol (Paris) 1998;154:40–44.
16.
Hu MTM, Ellis CM, Al-Chalari AA, Leigh PN, Shaw CE. Flail arm syndrome: a distinctive variant of amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 1998;65:950–951.
17.
Charcot JM. Lectures on the diseases of the nervous system. Sigerson G, trans. and ed. London: The New Sydenham Society, 1881:180–204.
18.
Jackson CE, Bryan WW. Amyotrophic lateral sclerosis. Semin Neurol 1998;18:27–39.
19.
Behnia M, Kelly JJ. Role of electromyography in amyotrophic lateral sclerosis. Muscle Nerve 1991;14:1236–1241.
20.
Brooks BR. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. J Neurol Sci 1994;124 (suppl):96–107.
21.
Chio A, Brignolio F, Leone M, et al. A survival analysis of 155 cases of progressive muscular atrophy. Acta Neurol Scand 1985;72:407–413.
22.
Aran FA. Recherches sur une maladie non encore décrite du système musculaire. Arch Gen Med 1850;24:5–35
23.
Duchenne de Boulogne GBA. Recherches faites à l’orde des galvanisine sur l’état de la contractilité et de la sensibilité électromusculaires dans les paralysies des membres supérieurs. CR Acad Sci 1849;29:667–670.
24.
Charcot JM, Joffroy A. Deux cas d’atrophie musculaire progressive. Arch Physiol Norm Pathol 1869;2:354–367.
25.
Tan E, Lynn DJ, Amato AA, et al. Immunosuppressive treatment of motor neuron syndromes: attempts to distinguish a treatable disorder. Arch Neurol 1994;51:194–200.
26.
Mortara P, Chio A, Rosso MG, Leone M, Schiffer D. Motor neuron disease in the province of Turin, Italy, 1996-1980: survival analysis in an unselected population. J Neurol Sci 1984;66:165–173.
27.
Norris F, Shepherd R, Denys E, et al. Onset, natural history and outcome in idiopathic adult motor neuron disease. J Neurol Sci 1993;118:48–55.
28.
Alcaz S, Jarebinski M, Pekmezovic T, Stevic-Marinkovic Z, Pavlovic S, Apostolski S. Epidemiological and clinical characteristics of ALS in Belgrade, Yugoslavia. Acta Neurol Scand 1996;94:264–268.
29.
Sobue I, Sato N, Iida M, Ando K. Juvenile type of distal and segmental muscular atrophy of upper extremities. Ann Neurol 1978;3:429–432.
30.
Hirayama K, Toyokura Y, Tsubaki T. Juvenile muscular atrophy of unilateral upper extremity: a new clinical entity. Psychiatric Neurol Jpn 1959;61:2190–2197.
31.
Peiris JB, Seneviratne KN, Wickremasinghe HR, Gunatilake SB, Gamage R. Non-familial juvenile distal spinal muscular atrophy of the upper extremity. J Neurol Neurosurg Psychiatry 1989;52:314–319.
32.
Donofrio PD. AAEM case report #28: monomelic amyotrophy. Muscle Nerve 1994;17:1129–1134.
33.
Hestnes A, Mellgren SI. Familial amyotrophic lateral sclerosis: report of a family with predominant upper limb pareses and late onset. Acta Neurol Scand 1980;61:192–199.
34.
Jansen PHP, Joosten EMG, Jaspar HHJ, Vingerhoets HM. A rapidly progressive autosomal dominant scapulohumeral form of spinal muscular atrophy. Ann Neurol 1986;20:538–540.
35.
Kennedy WR, Alter M, Sung JH. Progressive proximal spinal and bulbar muscular atrophy of late onset. Neurology 1968;18:671–680.
36.
Pearn JH, Hudgson P, Walton JN. A clinical and genetic study of spinal muscular atrophy (SMA) of adult onset: the autosomal recessive form as a discrete disease entity. Brain 1978;101:591–606.
37.
Moulard B, Salachas F, Chassande B, et al. Association between centromeric deletions of the SMN gene and sporadic adult-onset lower motor neuron disease. Ann Neurol 1998;43:640–644.
38.
Richieri-Costa A, Rogatko A, Levisky R, Finkel N, Frota-Pessoa O. Autosomal dominant late adult spinal muscular atrophy, type Finkel. Am J Med Genet 1981;9:119–128.
39.
Katz JS, Wolfe GI, Bryan WW, Jackson CE, Amato AA, Barohn RJ. Electrodiagnostic findings in multifocal motor neuropathy. Neurology 1997;48:700–707.
40.
Parry GJ, Clarke S. Multifocal acquired demyelinating neuropathy masquerading as motor neuron disease. Muscle Nerve 1988;11:103–107.
41.
Krarup C, Stewart JD, Sumner AJ, Pestronk A, Lipton SA. A syndrome of asymmetric limb weakness with motor conduction block. Neurology 1990;40:118–127.
42.
Pestronk A, Chaudry V, Feldman EL, et al. Lower motor neuron syndromes defined by patterns of weakness, nerve conduction abnormalities, and high titers of antiglycolipid antibodies. Ann Neurol 1990;27:316–326.
43.
Pradhan S, Gupta RK. Magnetic resonance imaging in juvenile asymmetric segmental spinal muscular atrophy. J Neurol Sci 1997;146:133–138.

Information & Authors

Information

Published In

Neurology®
Volume 53Number 5September 1, 1999
Pages: 1071
PubMed: 10496268

Publication History

Received: February 12, 1999
Accepted: April 24, 1999
Published online: September 1, 1999
Published in print: September 1, 1999

Permissions

Request permissions for this article.

Authors

Affiliations & Disclosures

J.S. Katz, MD
From the Departments of Neurology (Drs. Katz and Andersson) at Palo Alto VA Medical Center and Stanford UniversityPalo Alto, CA; University of Texas (Drs. Wolfe, Elliott, Nations, Bryan, and Barohn), Southwestern Medical Center, Dallas, TX; and Wilford Hall Medical Center (Dr. Saperstein), San Antonio, TX.
G.I. Wolfe, MD
From the Departments of Neurology (Drs. Katz and Andersson) at Palo Alto VA Medical Center and Stanford UniversityPalo Alto, CA; University of Texas (Drs. Wolfe, Elliott, Nations, Bryan, and Barohn), Southwestern Medical Center, Dallas, TX; and Wilford Hall Medical Center (Dr. Saperstein), San Antonio, TX.
P.B. Andersson, MD
From the Departments of Neurology (Drs. Katz and Andersson) at Palo Alto VA Medical Center and Stanford UniversityPalo Alto, CA; University of Texas (Drs. Wolfe, Elliott, Nations, Bryan, and Barohn), Southwestern Medical Center, Dallas, TX; and Wilford Hall Medical Center (Dr. Saperstein), San Antonio, TX.
D.S. Saperstein, MD
From the Departments of Neurology (Drs. Katz and Andersson) at Palo Alto VA Medical Center and Stanford UniversityPalo Alto, CA; University of Texas (Drs. Wolfe, Elliott, Nations, Bryan, and Barohn), Southwestern Medical Center, Dallas, TX; and Wilford Hall Medical Center (Dr. Saperstein), San Antonio, TX.
J.L. Elliott, MD
From the Departments of Neurology (Drs. Katz and Andersson) at Palo Alto VA Medical Center and Stanford UniversityPalo Alto, CA; University of Texas (Drs. Wolfe, Elliott, Nations, Bryan, and Barohn), Southwestern Medical Center, Dallas, TX; and Wilford Hall Medical Center (Dr. Saperstein), San Antonio, TX.
S.P. Nations, MD
From the Departments of Neurology (Drs. Katz and Andersson) at Palo Alto VA Medical Center and Stanford UniversityPalo Alto, CA; University of Texas (Drs. Wolfe, Elliott, Nations, Bryan, and Barohn), Southwestern Medical Center, Dallas, TX; and Wilford Hall Medical Center (Dr. Saperstein), San Antonio, TX.
W.W. Bryan, MD
From the Departments of Neurology (Drs. Katz and Andersson) at Palo Alto VA Medical Center and Stanford UniversityPalo Alto, CA; University of Texas (Drs. Wolfe, Elliott, Nations, Bryan, and Barohn), Southwestern Medical Center, Dallas, TX; and Wilford Hall Medical Center (Dr. Saperstein), San Antonio, TX.
R.J. Barohn, MD
From the Departments of Neurology (Drs. Katz and Andersson) at Palo Alto VA Medical Center and Stanford UniversityPalo Alto, CA; University of Texas (Drs. Wolfe, Elliott, Nations, Bryan, and Barohn), Southwestern Medical Center, Dallas, TX; and Wilford Hall Medical Center (Dr. Saperstein), San Antonio, TX.

Notes

Address correspondence and reprint requests to Dr. Jonathan Katz, Department of Neurology (127), Department of Veterans Affairs, 3801 Miranda Ave., Palo Alto, CA 94304.

Metrics & Citations

Metrics

Citation information is sourced from Crossref Cited-by service.

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

Cited By
  1. Lower motor neuron disease with MRI «snake eyes» pattern, S.S. Korsakov Journal of Neurology and Psychiatry, 124, 9, (141), (2024).https://doi.org/10.17116/jnevro2024124091141
    Crossref
  2. Clinical and serological insights into paraneoplastic brachial amyotrophic diplegia, Journal of Neurology, 271, 7, (4620-4627), (2024).https://doi.org/10.1007/s00415-024-12425-x
    Crossref
  3. All hands on deck: The multidisciplinary rehabilitation assessment and management of hand function in persons with neuromuscular disorders , Muscle & Nerve, (2024).https://doi.org/10.1002/mus.28167
    Crossref
  4. Variants of Amyotrophic lateral sclerosis and rehabilitation: an overview, Balneo and PRM Research Journal, 14, Vol.14, no.2, (559), (2023).https://doi.org/10.12680/balneo.2023.559
    Crossref
  5. Variants of Amyotrophic lateral sclerosis and rehabilitation: an overview, Balneo and PRM Research Journal, 14, Vol.14, no.2, (559), (2023).https://doi.org/10.12680/balneo.2022.559
    Crossref
  6. ‘Man-in-the-barrel’ syndrome: a case report of bilateral arm paresis following cardiac arrest, Annals of Medicine & Surgery, 85, 3, (464-467), (2023).https://doi.org/10.1097/MS9.0000000000000135
    Crossref
  7. The flail-arm syndrome: the influence of phenotypic features, Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 24, 5-6, (383-388), (2023).https://doi.org/10.1080/21678421.2022.2164205
    Crossref
  8. Nutrition, percutaneous endoscopic gastrostomy and ALS, Diet and Nutrition in Neurological Disorders, (141-153), (2023).https://doi.org/10.1016/B978-0-323-89834-8.00002-7
    Crossref
  9. Plexopatía braquial de inicio temprano como manifestación extraglandular atípica en el síndrome de Sjögren, Neurología Argentina, 14, 1, (51-55), (2022).https://doi.org/10.1016/j.neuarg.2021.02.001
    Crossref
  10. Biochemical and biophysical properties of the novel ALS-linked hSOD1 mutants: an experimental study accompanied by in silico analysis, Journal of the Iranian Chemical Society, 20, 1, (125-138), (2022).https://doi.org/10.1007/s13738-022-02660-2
    Crossref
  11. See more
Loading...

View Options

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.

If you need immediate support or to place an order, please call or email customer service:

  • 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
  • 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
  • [email protected]

We appreciate your patience during this time and apologize for any inconvenience.

View options

PDF and All Supplements

Download PDF and Supplementary Material

Full Text HTML

View Full Text HTML

Media

Figures

Other

Tables

Share

Share

Share article link

Share